Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Samuel C Mok

Showing results (101-110 of 144) with videos related to

Pageof 15
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 3, 2008
Increased HLA-DMB expression in the tumor epithelium is associated with increased CTL infiltration and improved prognosis in advanced-stage serous ovarian cancerMichael J Callahan, Zoltan Nagymanyoki, Tomas Bonome, et al.
Cancers|March 14, 2026
MicroRNA-625-3p Increases Chemosensitivity in Ovarian Cancer Cells Through Decreasing SSX2IP-Mediated Cisplatin Export in Extracellular VesiclesChi-Lam Au-Yeung, Tetsushi Tsuruga, Marina A Talor, et al.
Cancer Genetics and Cytogenetics|December 2, 2004
Identification of DNA copy number changes in microdissected serous ovarian cancer tissue using a cDNA microarray platformHiroshi Tsuda, Michael J Birrer, Yoichi M Ito, et al.
International Journal of Cancer|December 29, 2005
Selenium binding protein 1 in ovarian cancerKuan-Chun Huang, Dong Choon Park, Shu-Kay Ng, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 16, 2009
PAX2 expression in low malignant potential ovarian tumors and low-grade ovarian serous carcinomasCelestine S Tung, Samuel C Mok, Yvonne T M Tsang, et al.
Advances in Experimental Medicine and Biology|June 13, 2008
Classification of ovarian cancer: a genomic analysisMichael P Stany, Tomas Bonome, Fred Wamunyokoli, et al.
Reproductive Biology and Endocrinology : RB&E|June 26, 2010
Activated networking of platelet activating factor receptor and FAK/STAT1 induces malignant potential in BRCA1-mutant at-risk ovarian epitheliumLifang Zhang, Dan Wang, Wei Jiang, et al.
Cancers|January 8, 2020
Ubiquitin Carboxyl-Terminal Hydrolase L1 (UCHL1) Promotes Uterine Serous Cancer Cell Proliferation and Cell Cycle ProgressionSuet-Ying Kwan, Chi-Lam Au-Yeung, Tsz-Lun Yeung, et al.
Cancers|April 30, 2021
SIO: A Spatioimageomics Pipeline to Identify Prognostic Biomarkers Associated with the Ovarian Tumor MicroenvironmentYing Zhu, Sammy Ferri-Borgogno, Jianting Sheng, et al.
Neoplasia (New York, N.Y.)|April 27, 2007
Claudin-4 overexpression in epithelial ovarian cancer is associated with hypomethylation and is a potential target for modulation of tight junction barrier function using a C-terminal fragment of Clostridium perfringens enterotoxinBabak Litkouhi, Joseph Kwong, Chun-Min Lo, et al.
Pageof 15

Showing results (101-110 of 144) with videos related to

Sort By:
Pageof 15
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 3, 2008
Increased HLA-DMB expression in the tumor epithelium is associated with increased CTL infiltration and improved prognosis in advanced-stage serous ovarian cancerMichael J Callahan, Zoltan Nagymanyoki, Tomas Bonome, et al.
Cancers|March 14, 2026
MicroRNA-625-3p Increases Chemosensitivity in Ovarian Cancer Cells Through Decreasing SSX2IP-Mediated Cisplatin Export in Extracellular VesiclesChi-Lam Au-Yeung, Tetsushi Tsuruga, Marina A Talor, et al.
Cancer Genetics and Cytogenetics|December 2, 2004
Identification of DNA copy number changes in microdissected serous ovarian cancer tissue using a cDNA microarray platformHiroshi Tsuda, Michael J Birrer, Yoichi M Ito, et al.
International Journal of Cancer|December 29, 2005
Selenium binding protein 1 in ovarian cancerKuan-Chun Huang, Dong Choon Park, Shu-Kay Ng, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 16, 2009
PAX2 expression in low malignant potential ovarian tumors and low-grade ovarian serous carcinomasCelestine S Tung, Samuel C Mok, Yvonne T M Tsang, et al.
Advances in Experimental Medicine and Biology|June 13, 2008
Classification of ovarian cancer: a genomic analysisMichael P Stany, Tomas Bonome, Fred Wamunyokoli, et al.
Reproductive Biology and Endocrinology : RB&E|June 26, 2010
Activated networking of platelet activating factor receptor and FAK/STAT1 induces malignant potential in BRCA1-mutant at-risk ovarian epitheliumLifang Zhang, Dan Wang, Wei Jiang, et al.
Cancers|January 8, 2020
Ubiquitin Carboxyl-Terminal Hydrolase L1 (UCHL1) Promotes Uterine Serous Cancer Cell Proliferation and Cell Cycle ProgressionSuet-Ying Kwan, Chi-Lam Au-Yeung, Tsz-Lun Yeung, et al.
Cancers|April 30, 2021
SIO: A Spatioimageomics Pipeline to Identify Prognostic Biomarkers Associated with the Ovarian Tumor MicroenvironmentYing Zhu, Sammy Ferri-Borgogno, Jianting Sheng, et al.
Neoplasia (New York, N.Y.)|April 27, 2007
Claudin-4 overexpression in epithelial ovarian cancer is associated with hypomethylation and is a potential target for modulation of tight junction barrier function using a C-terminal fragment of Clostridium perfringens enterotoxinBabak Litkouhi, Joseph Kwong, Chun-Min Lo, et al.
Pageof 15